News
Australian researchers have demonstrated that the use of a new, less toxic drug combination after stem cell transplants for ...
Now that Ultomiris has matched the indications of its predecessor Soliris, AstraZeneca is eyeing new avenues for the C5 drug ...
In the first half of 2025, eight systems have performed first-of-their-kind procedures and clinical treatments. 1. Morgantown, W.Va.-based WVU Heart and Vascular Institute physicians completed the ...
Epkinly (epcoritamab) is a subcutaneously delivered CD3×CD20 BiTE that secured FDA accelerated approval in 2023 for r/r DLBCL.
Long-term exposure to particulate matter in patients with pulmonary arterial hypertension increases risk for lung transplantation or death.
8h
AllAfrica on MSNKenya: CS Duale Presides Over Sha-Nairobi Hospital Deal to Offer Cancer, Dialysis and Kidney Transplant Services Under UHCHealth Cabinet Secretary Aden Duale has commissioned East Africa's first AI-powered 256-slice CT scanner at The Nairobi Hospital, unveiling a major partnership between the Ministry of Health, the ...
12h
Public News Service on MSNASU research studies kidney transplants and their availabilityPatients with end-stage renal disease have two treatment options: dialysis or a kidney transplant but because donor kidneys ...
Transplantation with standard-criteria kidney offers a clear survival benefit, but this decreases with age and for those with a history of CVD.
By Stephanie Stahl, Brad Nau Click here for updates on this story PHILADELPHIA (KYW) -- A patient from Switzerland is ...
Data from the POLARGO trial potentially establishes a new standard of care for patients with R/R DLBCL ineligible for ...
The late-breaking abstracts presented on the last day of the 2025 European Hematology Association (EHA) Congress show “what a vibrant clinical specialty we’re in,” according to session cochair Brian ...
Omega-3 fatty acids by way of fish oil supplements didn't help to stave off renal decline in kidney transplant recipients, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results